Latest filings (excl ownership)
8-K
Regulation FD Disclosure
23 May 24
8-K
Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
15 May 24
10-Q
2024 Q1
Quarterly report
15 May 24
8-K
Departure of Directors or Certain Officers
6 May 24
ARS
2023 FY
Annual report to shareholders
18 Apr 24
DEFA14A
Additional proxy soliciting materials
18 Apr 24
DEF 14A
Definitive proxy
18 Apr 24
S-8
Registration of securities for employees
25 Mar 24
10-K
2023 FY
Annual report
25 Mar 24
8-K
Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
25 Mar 24
8-K
Departure of Directors or Certain Officers
2 Feb 24
8-K
Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock
30 Jan 24
EFFECT
Notice of effectiveness
26 Jan 24
8-K
Results of Operations and Financial Condition
24 Jan 24
S-1/A
IPO registration (amended)
24 Jan 24
S-1
IPO registration
23 Jan 24
CORRESP
Correspondence with SEC
23 Jan 24
CORRESP
Correspondence with SEC
23 Jan 24
8-K
Regulation FD Disclosure
22 Jan 24
UPLOAD
Letter from SEC
16 Jan 24
DRS
Draft registration statement
10 Jan 24
8-K
Departure of Directors or Certain Officers
29 Dec 23
8-K
Departure of Directors or Certain Officers
21 Nov 23
8-K
Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
13 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Regulation FD Disclosure
23 Oct 23
8-K
Regulation FD Disclosure
27 Sep 23
8-K
Sagimet Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
21 Aug 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
8-K
Regulation FD Disclosure
10 Aug 23
8-K
Departure of Directors or Certain Officers
27 Jul 23
8-K
Amendments to Articles of Incorporation or Bylaws
18 Jul 23
S-8
Registration of securities for employees
17 Jul 23
424B4
Prospectus supplement with pricing info
14 Jul 23
EFFECT
Notice of effectiveness
14 Jul 23
SEC STAFF
SEC staff action: Order
14 Jul 23
S-1MEF
Registration of additional securities for an S-1
13 Jul 23
CERT
Certification of approval for exchange listing
13 Jul 23
8-A12B
Registration of securities on exchange
11 Jul 23
CORRESP
Correspondence with SEC
11 Jul 23
Latest ownership filings
4
Thierry Chauche
8 May 24
3
Thierry Chauche
8 May 24
4
Timothy P Walbert
3 Apr 24
4
Paul W. Hoelscher
3 Apr 24
3
Timothy P Walbert
3 Apr 24
3
Paul W. Hoelscher
3 Apr 24
4
David Happel
28 Mar 24
SC 13G/A
FMR LLC
11 Mar 24
SC 13G
NEW ENTERPRISE ASSOCIATES 13 LP
14 Feb 24
SC 13G
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
14 Feb 24
SC 13G
BAKER BROS. ADVISORS LP
14 Feb 24
SC 13G
KPCB PANDEMIC & BIO DEFENSE FUND LLC
14 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
SC 13G
Point72 Asset Management, L.P.
5 Feb 24
3
Joseph Oriti
2 Feb 24
4
SCOTT D SANDELL
31 Jan 24
4
PATRICK J KERINS
31 Jan 24
4
FOREST BASKETT
31 Jan 24
4
Change in insider ownership
31 Jan 24
4
Change in insider ownership
31 Jan 24
4
David Happel
8 Dec 23
4
Elizabeth Rozek
21 Nov 23
4
George Kemble
21 Nov 23
4
David Happel
21 Nov 23
4
Eduardo Bruno Martins
21 Nov 23
4
David Happel
20 Nov 23
SC 13G
FMR LLC
11 Sep 23
4
George Kemble
8 Sep 23
4
PATRICK J KERINS
20 Jul 23
4
Change in insider ownership
20 Jul 23
4
BETH C SEIDENBERG
20 Jul 23
4
Jinzi Jason Wu
20 Jul 23
4
Elizabeth Rozek
20 Jul 23
4
Richard J Rodgers
20 Jul 23
4
Anthony M Rimac
20 Jul 23
4
Merdad Parsey
20 Jul 23
4
Eduardo Bruno Martins
20 Jul 23
4
George Kemble
20 Jul 23
4
Dennis Hom
20 Jul 23
4
David Happel
20 Jul 23